title: [Consultation after cerebral infarction or intracerebral hematoma].
abstract: Hypertension is the principal risk factor for cerebral infarctions and intracerebral hematoma. The brain is the principal target of hypertension. The brain is the principal target of antihypertensive drugs. Controlling blood pressure and stopping smoking reduces the risk of cerebral infarction by 40%. Objectives of a consultation after cerebral infarction or intracerebral hematoma: validate diagnosis and cause, identify risk factors for recurrent cerebral infarction but also for myocardial infarction and lower limb arterial disease, begin treatment of the risk factors for recurrence, begin prevention of atherothrombotic complications and embolic heart disease, identify complications of cerebral infarction and intracerebral hematoma.
authors.affiliation: Service de neurologie, Réseau Bourgogne-AVC (URCAM-ARH), CHU, Dijon.
authors.forename: Isabelle
authors.initials: I
authors.lastname: Benatru
authors.forename: Fabienne
authors.initials: F
authors.lastname: Contegal
authors.forename: Olivier
authors.initials: O
authors.lastname: Rouaud
authors.forename: Marie
authors.initials: M
authors.lastname: Caillier
authors.forename: Michael
authors.initials: M
authors.lastname: Menassa
authors.forename: Guy-Victor
authors.initials: GV
authors.lastname: Osseby
authors.forename: Bernard
authors.initials: B
authors.lastname: Vernet
authors.forename: Jérôme
authors.initials: J
authors.lastname: Durier
authors.forename: Agnès
authors.initials: A
authors.lastname: Fromont
authors.forename: Thibault
authors.initials: T
authors.lastname: Moreau
authors.forename: Maurice
authors.initials: M
authors.lastname: Giroud
mesh_terms: D000328:Adult; D000368:Aged; D000959:Antihypertensive Agents / Q000627:therapeutic use; D016893:Carotid Stenosis / Q000150:complications; D002543:Cerebral Hemorrhage / Q000150:complications / Q000175:diagnosis / Q000209:etiology / Q000517:prevention & control*; D002544:Cerebral Infarction / Q000150:complications / Q000175:diagnosis / Q000209:etiology / Q000517:prevention & control*; D003276:Contraceptives, Oral / Q000009:adverse effects; D048909:Diabetes Complications; D015444:Exercise; D005260:Female; D006406:Hematoma / Q000150:complications / Q000517:prevention & control; D006801:Humans; D006949:Hyperlipidemias / Q000150:complications / Q000188:drug therapy / Q000517:prevention & control; D006973:Hypertension / Q000150:complications / Q000188:drug therapy / Q000517:prevention & control; D007239:Infections / Q000150:complications; D007866:Leg / Q000098:blood supply; D008297:Male; D009203:Myocardial Infarction / Q000517:prevention & control; D009747:Nutritional Physiological Phenomena; D009765:Obesity / Q000150:complications / Q000628:therapy; D012008:Recurrence; D012306:Risk; D012307:Risk Factors; D012907:Smoking / Q000009:adverse effects; D016540:Smoking Cessation; D013997:Time Factors; D015431:Weight Loss
chemical_list: D000959:Antihypertensive Agents; D003276:Contraceptives, Oral